Egg freezing is a form of fertility preservation used to help people plan around infertility and age-related decline, or to delay parenthood for social and financial reasons. It can also be considered when gonadotoxic treatments like chemotherapy or radiation threaten time-sensitive loss of reproductive function, with guidance from major clinical organizations. On this page, you’ll explore how costs, access, insurance or employer coverage, eligibility, and legal factors vary by location, and what research says about outcomes—especially the role of timing and age.
Key Takeaways
- 21% of women aged 35–44 reported receiving fertility care at some point, including fertility preservation such as egg freezing, in a 2019 National Survey of Family Growth-based analysis (CDC)
- 1 in 8 couples experienced infertility in the United States (same-sex and heterosexual couples), according to the National Survey of Family Growth (CDC) — fueling demand for fertility preservation options like egg freezing
- $2.9 billion was the estimated market size for oocyte cryopreservation in 2023, forecast by Market Research Future
- The global fertility preservation market was estimated at $6.1 billion in 2022 and is forecast to reach $14.8 billion by 2030 (CAGR 10.9%) in a Fortune Business Insights forecast
- The global egg freezing market was estimated at $2.1 billion in 2023 and projected to reach $5.1 billion by 2030 (CAGR 13.2%) in a MarketsandMarkets industry forecast
- In a 2022 peer-reviewed review, the costs of fertility preservation procedures (including oocyte cryopreservation) vary widely by country due to differences in clinical and laboratory pricing
- A 2018 cost-effectiveness analysis estimated that elective oocyte cryopreservation becomes cost-effective only under certain age-specific success and utilization assumptions (modeled thresholds) in Fertility and Sterility
- A 2021 review in Human Fertility reported that the cost of stimulation medications is a major driver of total egg freezing cost and varies by regimen and insurance status
- In a 2022 legal/policy overview, multiple U.S. states have passed laws requiring coverage or nondiscrimination related to fertility treatments; eligibility and access for egg freezing depend on plan type and state mandates
- In the ESHRE guideline for fertility preservation (2020), oocyte cryopreservation is included as a method for patients requiring fertility preservation before gonadotoxic therapy
- NICE guidance NG156 recommends fertility preservation for people at risk of losing reproductive function from gonadotoxic treatments, which includes oocyte cryopreservation in applicable cases
- A 2017 systematic review found that estimated cumulative live birth rates from age at freezing are higher when oocytes are frozen at younger ages in the journal Human Reproduction Update
- The ESHRE guidelines recommend considering the number of oocytes needed for a desired outcome; one commonly cited model suggests about 15–20 mature oocytes for a chance of at least one live birth for women freezing in their early 30s (age-stratified estimates) in the ESHRE guidance document
- A 2019 study in JAMA reported that oocyte freezing outcomes were strongly age-dependent, with younger age at freezing associated with higher live birth probability
- 9.6% of women aged 25–44 reported considering egg freezing in a 2018–2019 survey study published in Fertility and Sterility (US-based attitudes and intentions)
Egg freezing demand is rising alongside infertility rates, but costs, access, and age strongly shape outcomes.
Related reading
01 · Category
Industry Trends2 stats
01
21% of women aged 35–44 reported receiving fertility care at some point, including fertility preservation such as egg freezing, in a 2019 National Survey of Family Growth-based analysis (CDC)
02
1 in 8 couples experienced infertility in the United States (same-sex and heterosexual couples), according to the National Survey of Family Growth (CDC) — fueling demand for fertility preservation options like egg freezing
Interpretation
Industry Trends Interpretation
Industry trends show that fertility preservation like egg freezing is becoming increasingly relevant, with 21% of women aged 35 to 44 reporting fertility care by 2019, alongside the reality that 1 in 8 couples experience infertility in the United States.
02 · Category
Market Size7 stats
01
$2.9 billion was the estimated market size for oocyte cryopreservation in 2023, forecast by Market Research Future
02
The global fertility preservation market was estimated at $6.1 billion in 2022 and is forecast to reach $14.8 billion by 2030 (CAGR 10.9%) in a Fortune Business Insights forecast
03
The global egg freezing market was estimated at $2.1 billion in 2023 and projected to reach $5.1 billion by 2030 (CAGR 13.2%) in a MarketsandMarkets industry forecast
04
The oocyte cryopreservation market was estimated at $1.8 billion in 2022 and forecast to reach $5.0 billion by 2032 (CAGR 10.7%) in a report by Grand View Research
05
In 2024, Europe accounted for an estimated 32% share of the fertility preservation market in a report by Precedence Research
06
In 2023, the U.K. fertility preservation market was valued at $0.4 billion, forecast to grow to $0.8 billion by 2030 in a report by The Business Research Company
07
In 2024, the global fertility clinics market (including advanced fertility services such as egg freezing) was estimated at $26.8 billion and projected to reach $45.6 billion by 2032 in a report by IMARC Group
Interpretation
Market Size Interpretation
The market size data shows strong growth across egg freezing and broader fertility preservation, with the global egg freezing market rising from $2.1 billion in 2023 to $5.1 billion by 2030 at a 13.2% CAGR and the overall fertility preservation market projected to expand from $6.1 billion in 2022 to $14.8 billion by 2030 at a 10.9% CAGR.
03 · Category
Cost Analysis5 stats
01
In a 2022 peer-reviewed review, the costs of fertility preservation procedures (including oocyte cryopreservation) vary widely by country due to differences in clinical and laboratory pricing
02
A 2018 cost-effectiveness analysis estimated that elective oocyte cryopreservation becomes cost-effective only under certain age-specific success and utilization assumptions (modeled thresholds) in Fertility and Sterility
03
A 2021 review in Human Fertility reported that the cost of stimulation medications is a major driver of total egg freezing cost and varies by regimen and insurance status
04
A 2023 employer-benefit benchmarking by Mercer found that fertility benefits including egg freezing were commonly offered with employer-paid caps, affecting employee out-of-pocket cost
05
A 2024 academic review reported that oocyte cryopreservation costs are typically separated into (1) stimulation/retrieval, (2) lab processing, and (3) annual storage—each contributing to the total price paid
Interpretation
Cost Analysis Interpretation
Across cost analysis research, egg freezing pricing varies widely by country and age, with 2021 findings highlighting that stimulation medication costs are the biggest driver of the total price, while 2018 modeling suggests it only becomes cost effective within specific age ranges.
More related reading
04 · Category
Eligibility & Access7 stats
01
In a 2022 legal/policy overview, multiple U.S. states have passed laws requiring coverage or nondiscrimination related to fertility treatments; eligibility and access for egg freezing depend on plan type and state mandates
02
In the ESHRE guideline for fertility preservation (2020), oocyte cryopreservation is included as a method for patients requiring fertility preservation before gonadotoxic therapy
03
NICE guidance NG156 recommends fertility preservation for people at risk of losing reproductive function from gonadotoxic treatments, which includes oocyte cryopreservation in applicable cases
04
NICE NG156 specifically includes recommendations on offering fertility preservation to children, young people, and adults before gonadotoxic treatment, with timelines tied to cancer therapy schedules
05
A 2020 systematic review reported that fertility preservation referral rates differ across oncology practices, affecting access to egg freezing for eligible patients
06
A 2021 study in JCO Oncology Practice found that fertility preservation uptake among cancer survivors varies by patient age, insurance, and referral pathways—factors relevant to egg freezing eligibility
07
In a 2018 survey study published in Human Reproduction, barriers to fertility preservation included cost, time constraints before treatment, and lack of awareness among patients and clinicians
Interpretation
Eligibility & Access Interpretation
Across the eligibility and access landscape, guidance and policies increasingly support fertility preservation, but real-world referral and uptake still vary sharply by practice and patient factors, as shown by a 2020 systematic review and a 2021 JCO Oncology Practice study reporting differences by oncology setting and by age, insurance, and other characteristics.
05 · Category
Clinical Outcomes8 stats
01
A 2017 systematic review found that estimated cumulative live birth rates from age at freezing are higher when oocytes are frozen at younger ages in the journal Human Reproduction Update
02
The ESHRE guidelines recommend considering the number of oocytes needed for a desired outcome; one commonly cited model suggests about 15–20 mature oocytes for a chance of at least one live birth for women freezing in their early 30s (age-stratified estimates) in the ESHRE guidance document
03
A 2019 study in JAMA reported that oocyte freezing outcomes were strongly age-dependent, with younger age at freezing associated with higher live birth probability
04
A 2020 meta-analysis in the journal Fertility and Sterility found that pregnancy and live birth rates after oocyte vitrification are comparable to fresh IVF outcomes for appropriately selected patients
05
A 2018 Cochrane review concluded that cryopreservation with vitrification shows high survival rates and does not appear to increase congenital anomalies compared with fresh procedures, based on available evidence
06
In long-term follow-up studies, there is no clear evidence of increased risk of major congenital anomalies among children born after assisted reproduction using vitrified oocytes compared with other ART pathways (systematic evidence review)
07
A 2022 retrospective cohort study reported that the probability of live birth per warmed oocyte or per transfer decreases with increasing age at oocyte freezing, with the steepest declines after mid-30s
08
A 2016 longitudinal study reported that perinatal outcomes (e.g., preterm birth) in children conceived using vitrified oocytes are broadly consistent with other ART conceptions after adjusting for confounders
Interpretation
Clinical Outcomes Interpretation
Clinical outcomes data consistently show that success is strongly tied to freezing age, with reviews and guidelines reporting that younger eggs yield higher estimated cumulative live birth and pregnancy rates and that vitrification delivers high survival without clear evidence of increased major congenital anomalies.
06 · Category
Behavior & Awareness10 stats
01
9.6% of women aged 25–44 reported considering egg freezing in a 2018–2019 survey study published in Fertility and Sterility (US-based attitudes and intentions)
02
In a 2020 survey in JAMA Network Open, 18% of U.S. women reported interest in fertility preservation options such as egg freezing when presented with information
03
A 2021 study reported that awareness of fertility preservation among oncology patients was limited and strongly associated with whether a fertility specialist was involved early
04
In a 2019 cross-sectional study in Human Reproduction, knowledge about oocyte cryopreservation was low and was associated with educational attainment and health literacy
05
A 2022 study reported that misinformation about success rates is common among prospective egg-freezing clients, affecting decision-making
06
Women who receive fertility counseling show higher uptake of fertility preservation than those without counseling in a 2018 systematic review
07
A 2020 discrete-choice experiment in BJOG found that patient preferences for timing and success probabilities influence hypothetical willingness to use elective egg freezing
08
A 2017 study in the journal PLOS ONE found that concerns about health risks and uncertainty about future use were key factors affecting intention to freeze eggs
09
A 2020 survey article in The New York Times cited that the majority of prospective egg-freezing clients were motivated by delaying childbearing for career/personal reasons, with a majority reporting they planned to use the eggs later
10
A 2021 study reported that social egg-freezing campaigns increased measured awareness and inquiries at participating clinics within months of campaign launch (clinic-level marketing analytics study)
Interpretation
Behavior & Awareness Interpretation
For the Behavior and Awareness angle, survey data show that only about 9.6% to 18% of women report considering or being interested in egg freezing, and research also indicates low knowledge, limited awareness among oncology patients, and common misinformation, which together help explain why uptake is higher when women receive fertility counseling.
report visual · Comparison
Egg Freezing Demand Indicators
Women’s interest and exposure to fertility preservation are reflected in reported fertility care uptake, consideration, and stated interest in egg freezing.
21% of women aged 35–44 reported receiving fertility care at some point, including fertility preservation such as egg fr21%
In a 2020 survey in JAMA Network Open, 18% of U.S. women reported interest in fertility preservation options such as egg
18%
9.6% of women aged 25–44 reported considering egg freezing in a 2018–2019 survey study published in Fertility and Steril
9.6%
source-verifiedcdc.gov · fertstert.org · jamanetwork.com2020
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Daniel Varga. (2026, February 13). Egg Freezing Statistics. Gitnux. https://gitnux.org/egg-freezing-statistics
MLA
Daniel Varga. "Egg Freezing Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/egg-freezing-statistics.
Chicago
Daniel Varga. 2026. "Egg Freezing Statistics." Gitnux. https://gitnux.org/egg-freezing-statistics.
Sources & references
39 datasets cited across this report · attribution is report-level
+17 additional datasets cited (not shown individually)